Breaking News
Get 45% Off 0
👀 Ones to Watch: The MOST undervalued stocks to buy right now
See Undervalued Stocks
Close

Breaking News

U.S. stocks open lower amid Trump tariff threats, producer price data

Gp&g Fund Multistrategy Rx (0P0000KKD9)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
130.847 -1.310    -0.99%
11/03 - Delayed Data. Currency in EUR
Type:  Fund
Market:  Luxembourg
Issuer:  Generali Investments Luxembourg SA
ISIN:  LU0364482454 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 181.29M
GP&G Fund Multistrategy RX 130.847 -1.310 -0.99%

0P0000KKD9 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the GP&G Fund Multistrategy RX (0P0000KKD9) fund. Our GP&G Fund Multistrategy RX portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from Watchlist  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 13.020 14.830 1.810
Stocks 49.060 49.750 0.690
Bonds 24.890 25.530 0.640
Convertible 0.310 0.310 0.000
Preferred 0.010 0.010 0.000
Other 12.730 51.250 38.520

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 17.593 16.492
Price to Book 2.760 2.532
Price to Sales 1.953 1.885
Price to Cash Flow 11.849 10.312
Dividend Yield 2.309 2.408
5 Years Earnings Growth 9.641 11.374

Sector Allocation

Name  Net % Category Average
Technology 25.430 21.109
Industrials 13.340 11.964
Financial Services 12.950 15.995
Consumer Cyclical 10.570 12.562
Healthcare 10.480 11.971
Communication Services 8.060 7.828
Utilities 5.630 2.754
Energy 5.490 3.133
Consumer Defensive 4.660 7.470
Basic Materials 1.870 6.598
Real Estate 1.510 2.841

Region Allocation

  • North America
  • Latin America
  • Europe Developed
  • Asia
  • Australasia
  • Africa & Middle East
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 30

Number of short holdings: 1

Name ISIN Weight % Last Change %
  UBS plc MSCI ACWI SF hedged EUR A-acc IE00BYM11K57 13.01 206.80 -0.24%
  JPMorgan ETFs (Ireland) ICAV - Global Research Enh IE00BF4G6Y48 10.92 49.22 -1.00%
  WisdomTree Physical Gold JE00B1VS3770 6.88 275.07 +0.40%
  Italy 4.912 15-Apr-2032 IT0005594467 5.40 100.250 -0.13%
  Italy 0 14-Feb-2025 IT0005582868 5.30 99.992 0.00%
  Schroder International Selection Fund QEP Global C LU0106255481 4.88 61.189 -0.74%
QSF - Quaestio Global Enhanced Csh I Acc LU0971117741 4.43 - -
  Generali Investments SICAV - Euro Bond Fund BX LU0145476148 4.23 216.320 -0.27%
T. Rowe Price US Struct Rsh Eq I9 USD LU2648078678 3.81 - -
  DGC Stock Selection B EUR Acc LU0998532633 3.31 259.263 -2.06%

Top Equity Funds by Generali Investments Luxembourg SA

  Name Rating Total Assets YTD% 3Y% 10Y%
  Generali Komfort Dynamik Europa 1.39B 6.33 5.88 4.68
  LU0145456207 473.17M 5.93 6.67 5.02
  Generali invs SICAV SRI Euro EqAY 473.17M 10.36 10.45 6.09
  LU0169244745 473.17M 5.87 5.93 4.32
  Generali invs SICAV SRI Euro EqAX 473.17M 6.04 7.90 6.25
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000KKD9 Comments

Write your thoughts about Gp&g Fund Multistrategy Rx
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email